Multiple Sclerosis
Virtual Grand Rounds

Although the precise etiology of multiple sclerosis (MS) is unknown, knowledge about the disease and therapeutic strategies has expanded greatly in the past few decades. For many patients, the availability of disease-modifying therapy has changed the course of MS, and continued research is expanding therapeutic choices. Nevertheless, patients with MS continue to struggle with issues related to quality of life.

This educational initiative is designed to provide healthcare providers with the most current information about the identification, management, and treatment of patients with MS, with the goal of improving clinical outcomes and enhancing patient quality of life.

In this Virtual Grand Rounds series, a panel of MS experts will use a series of case-based activities to demonstrate best clinical practices in the care of patients with MS.

Target Audience

The target audience consists of neurologists and other healthcare professionals who manage patients with MS.

Webcasts
	Risks and Benefits of Therapy I: Focus on Natalizumab and Mitoxantrone J. Theodore Phillips, MD, PhD, FAAN
	Estimated Time: 1 hour Release Date:  September 30, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: September 30, 2012 Specialties: Neurology
	Comorbidity, Quality of Life, and Treatment in Multiple Sclerosis Ruth Ann Marrie, MD, PhD, FRCP(C)
	Estimated Time: 45 minutes Release Date:  August 31, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: August 31, 2012 Specialties: Neurology
	Emerging Oral Disease – Modifying Therapies for Multiple Sclerosis Timothy West, MD
	Estimated Time: 30 minutes Release Date:  August 4, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: August 4, 2012 Specialties: Neurology
	Adherence to Multiple Sclerosis Disease– Modifying Therapies Aaron P. Turner, PhD
	Estimated Time: 30 minutes Release Date:  July 11, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: July 11, 2012 Specialties: Neurology
	Improving Mobility for Patients with MS: Pharmacologic and Nonpharmacologic Approaches Francois Bethoux, MD
	Estimated Time: 1 hour Release Date:  June 14, 2011 Type: Webcast	Technical Requirements: Flash Player Expiration Date: June 14, 2012 Specialties: Neurology

Series Objectives

1. Select appropriate therapy for patients with MS at different junctures of the disease course.
2. Determine whether a patient with MS is adequately responding to treatment.
3. Discuss with a patient the potential risks and benefits of new and emerging MS therapies.
4. Consider issues that affect MS patients’ quality of life when making treatment decisions.

Ask the Expert

Using the Ask the Expert portal, participants have the opportunity to submit questions about the case to the Activity Director, Alexander D. Rae-Grant, MD.  To access this feature, begin the activity and enter your question(s) in the box at the bottom of the screen.

Activity Director

Alexander D. Rae-Grant, MD
Clinical Associate Professor of Medicine
Cleveland Clinic Lerner College of Medicine
Director of Resident and Student Education
Mellen Center for Multiple Sclerosis Treatment
  and Research
Cleveland, Ohio